Xiawei Cheng
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Physiology top 10%
- Calcium signaling and nucleotide metabolism
Papers in
-
- Protein Degradation and Inhibitors 2
- RNA Interference and Gene Delivery 2
- Mitochondrial Function and Pathology 2
-
- Cancer Research and Treatments 6
- Co-authors
- Weixia Sun (1 shared paper)Mengshu Jia (2 shared papers)Zichun Hua (6 shared papers)Weihua Gong (4 shared papers)Qiming Sun (4 shared papers)Jianxiang Chen (4 shared papers)Yi Yang (1 shared paper)Zhuo Zhang (1 shared paper)
In The Last Decade
Xiawei Cheng
17 papers receiving 675 citations
Xiawei Cheng's Hit Papers
Peers
Comparison fields: 5 of 82
- Biotechnology 170
- Physiology 37
- Cancer Research 76
- Geriatrics and Gerontology 16
- Epidemiology 152
Countries citing papers authored by Xiawei Cheng
This map shows the geographic impact of Xiawei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiawei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiawei Cheng more than expected).
Fields of papers citing papers by Xiawei Cheng
This network shows the impact of papers produced by Xiawei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiawei Cheng. The network helps show where Xiawei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiawei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lactate is a bridge linking glycolysis and autophagy through lactylation Hit paper breakdown → | 2023 | 109 |
| 2 | 2019 | 96 | |
| 3 | 2017 | 78 | |
| 4 | 2017 | 61 | |
| 5 | 2020 | 59 | |
| 6 | 2021 | 54 | |
| 7 | 2011 | 51 | |
| 8 | 2011 | 31 | |
| 9 | 2014 | 27 | |
| 10 | 2019 | 23 | |
| 11 | 2016 | 20 | |
| 12 | 2025 | 18 | |
| 13 | 2020 | 18 | |
| 14 | 2014 | 17 | |
| 15 | 2010 | 14 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 1 |
About Xiawei Cheng
Xiawei Cheng is a scholar working on Molecular Biology, Biotechnology, Epidemiology, Biomedical Engineering and Genetics, having authored 17 papers that have together received 681 indexed citations. Recurring topics across this work include Cancer Research and Treatments (6 papers), Autophagy in Disease and Therapy (4 papers), Nanoplatforms for cancer theranostics (4 papers), Virus-based gene therapy research (3 papers), Protein Degradation and Inhibitors (2 papers), RNA Interference and Gene Delivery (2 papers), Mitochondrial Function and Pathology (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Biotechnology (170 citations), Physiology (37 citations), Cancer Research (76 citations), Geriatrics and Gerontology (16 citations) and Epidemiology (152 citations). Xiawei Cheng has collaborated with scholars based in China, Czechia and Poland. Frequent co-authors include Weixia Sun, Mengshu Jia, Zichun Hua, Weihua Gong, Qiming Sun, Jianxiang Chen, Yi Yang, Zhuo Zhang, Yuzheng Zhao and Zhirong Shen. Their work appears in journals such as Molecular Cell, Cancer Science, Theranostics, Nature Communications and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.